Document 30LoXmaEkOVexkjgg700V9bx

t i u ; t i n ' t it *i r i tt** ' M V' Mt' 't '< l\:>ii * 1 \ " June to ,2006 x *|3f 1 ,i*- I f 1 Document Control Office Docket AR-226 EPA Hast Building, Room 6428 1201 Constitution Ave., NAV, Washington, DC 20460 Phone: 202-564-8030 Attention: OPPT Docket No. AR-226 {Mary Dominiak - Room 4410) Re: Information on Pertluorooctane Sulfonate, Pertluorooctanoic Acid, and Related Compounds Dear Ms. Dominiak: This continues 3M's voluntary submissions of data on perfluorooctane sulfonate (PFOS), pertluorooctanoic acid <PFOA), and related compounds. We are enclosing for the docket paper copies of the following three studies: Final Report, "Pilot Study to Assess the Serum Fluorochemical Concentrations in American Red Cross Blood Donors, 2005," 3M Medical Department Epidemiology, 2206W-08, January 0, 2006; Final Report, "Self-Reported Medical Conditions in Perfluorooctanesulfonyl Fluoride Manufacturing Workers," University of Minnesota School of Public Health. February i, 2006;and Final Report, "An Analysis of the 2000 Fluorochemical {Perfluorooctanoate, PFOA) Medical Surveillance Program at 3M Company's Antwerp {Belgium), Cottage Grove {Minnesota), and Decatur (Alabama) Facilities," 3M Medical Department Epidemiology. 220-3W-05, May 16,2006. Please feel free to contact me with any questions'. Very truly yours, Enclosures Michael A. Santoro Director of Environmental Health Safety and Regulatory Affairs Enterprise Services 3M Center, Building 236-I B - 10 St. Paul, MN 55144^ 651-733-6374 (phone) 651-733-1958 (fax) E-maiI: masantoroC mmm.com Dr. Charles Auer Dr. Jennifer Seed Dr. Osear \ ernunJez